Biohaven Pharmaceutical Holding Co Ltd.
(
BHVN)
Zavegepant nasal spray (NDA)
Q1 2023
FDA decision on Zavegepant nasal spray for the acute treatment of migraine in adults.
Pending-
NexoBrid (Resubmitted BLA)
01/01/2023
FDA decision on NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns
FDA approved NexoBrid for the removal of eschar in adults with deep partial-thickness and/or full-thickness thermal burns on Dec.29, 2022-
Vericel Corporation
(
VCEL)
NexoBrid (Resubmitted BLA)
01/01/2023
FDA decision on NexoBrid for eschar removal (debridement) in adults with deep partial-thickness and/or full-thickness thermal burns
FDA approved NexoBrid for the removal of eschar in adults with deep partial-thickness and/or full-thickness thermal burns on Dec.29, 2022-